periphEX

Over one billion people around the world suffer from Peripheral Neuropathy, a painful, debilitating, and chronic disease very common among diabetic patients. Peripheral Neuropathy damages the nerves at the extremities due to a lack of oxygen supply. PeriphEX developed a proprietary nanotechnology-based solution that diffuses Oxygen Nanobubbles to the peripheral nerves. Clinical studies have shown to significantly alleviate the pain symptoms of foot Peripheral Neuropathy in over 60% of the patients. The company started revenue in 2019 and is already having repeat sales. PeriphEX is led by an experienced team with cumulative eight exits under their belt. The company raised $175K pre-seed in 2019 and is now seeking $250K seed investment to fund operations and market launch. The founder, Dr. Zvi Yaniv, is a world renown nanotechnology expert. DR. Yaniv came up with this concept after he was diagnosed with Peripheral Neuropathy. He first experimented with oxygen nanobubbles on himself, and after realized significant improvement he started the clinical studies with dozens of other patients, resulting good outcomes, and already repeat sales from happy customers.